NFE2L2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Moreover, unlike highly glycolytic cells with high NRF2 activity, which are uniquely sensitive to NRF2 inhibition41,71, tRCC cells are only modestly sensitive to NFE2L2 knockdown (42 and data not shown).